ambrey-geneticsambry-geneticsbmi-healthcareBMIbrca-test-ukbrcabupacardio-dxcolordowndownloadfacebookforwardhalio-dxhca-healthcareHCAhearticon-burgericon-closeicon-githubicon-twitternanostringnuffield-healthnuffieldoncodnaoncomarkribbonskylinevideovitality coloricon-github
OncoDEEP logo

Is OncoDEEP the right test for you?

This test is about helping you and your clinician determine the best treatment plan for you based on the analysis of your tumour. It looks for the presence of specific biomarkers and can identify how your cancer is likely to respond to classic chemotherapies as well as other targeted therapies and immunotherapies.

It is relevant if you have Stage III of any cancer tumour – or Stage IV in any cancer other than Breast HR+ /HR2+, Colon, Prostate, NSCLC (Non-Small Cell Lung Cancer) or CUP (Cancer of Unknown Primary). For these cancers, see our OncoSTRAT&GO test – Click here.

Ask your clinician how you can get this test.

Oncodna do not allow their pricing to be made public

Why?Close tab

For you

There are huge number of drugs and therapies to treat cancers, and the more your clinician knows about the exact composition and behaviour of your tumour, the better they will be able to specify the combination that will be most effective for you in terms of survival rates and quality of life.

New treatments – or those you don’t need

OncoDEEP results cover all therapies with potential clinical benefit – possibly including those which have not been considered for you before.

It will also help determine which ones which are not likely to benefit you, so you avoid unnecessary treatments (and any associated side effects and cost).

You can discuss this with your clinician, or if you would like to talk to one of our experts about this test, call us on +44 (0) 1270 623 179

Patient story

“Earlier this year my sister died of breast cancer and not long after, I was diagnosed with cancer too. It’s terminal. Unfortunately, the doctors were unable to find the origin of my cancer – I was offered chemotherapy, but they didn’t know if I would respond, so I decided to forego it. “

“I was worried about other family members, but the doctors said my cancer was very different from my sister’s and there wasn’t a strong enough link to warrant them being tested. Then I heard about OncoDNA. Within a week, I had test results which showed my cancer was likely to have originated in my ovaries, that I had a BRCA-1 gene mutation and that I might respond better to a certain type of chemotherapy – but not other treatments. I was referred to an ovarian cancer specialist and I began treatment two weeks ago. The findings also mean that my daughter and nieces will now be screened. “

“My cancer is still terminal, but I now have the chance of extending my time here with my family. I am telling my story because I want other people to have the same chance to have an extended life, or get the most effective life-saving treatment at the earliest opportunity.”

How?Close tab

What do I have to do?

This test is an analysis of your tumour tissue. You will have had a biopsy before you received your cancer diagnosis, and we can use the sample taken at that time so you do not need an additional medical procedure to take this test.

ProcessClose tab

Through your Clinician

This test is only available through your clinician, who will receive your test results directly.

Step 1.

Buy the test. You will receive an email asking you to confirm that you have authorised Everything Genetic Ltd to be given a sample of your tumour tissue.

Step 2.

We will contact your pathologist directly and organise the collection of your sample and delivery to the lab.

Step 3: Reporting

Your sample will be analysed and a report will be generated, usually within seven working days of receipt of your sample in the laboratory.

Step 4: Results

We analyse the cancer genes by deep sequencing and looking at protein effectors and any validated biomarkers. Your clinician will receive a comprehensive report covering all of these elements together with details of specific therapies and clinical trials relevant to you.

CliniciansClose tab

Onco DNA Tests information for Clinicians

OncoDNA’s innovative approach is to combine next-generation sequencing (NGS) with immunohistochemistry (IHC). This gives a comprehensive view of a tumour profile, at both DNA and protein levels and opens more therapeutic options for your patient.

In 2016, liquid biopsy analyses were added to its solution portfolio, either in combination with solid biopsy analysis or as a stand-alone analysis for diagnostic or monitoring purposes.

Compare our four solutions to see which is right for your patient:

download-iconOncoDEEP – cost-effective solution combining DNA and protein analysis of a solid tumour sample

download-iconOncoSTRAT&GO – complete solution integrating the analyses of solid and liquid biopsies

download-iconOncoSELECT – cancer-specific solution from a liquid biopsy sample

This test is provided by:


Frequently asked questions

Do I need a doctor to authorise this test?
Yes, your doctor will need to provide the sample required for this test
Will my health insurance cover the cost of this test?
Many health insurance plans cover the cost of genetic testing – check with your provider to find out if it is in your policy.
How soon do I get my results?
Usually within seven working days of receipt of your sample in the laboratory.